Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $20.0 million.

  • Rockwell Medical's Non-Current Assets fell 1266.02% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.1 million, marking a year-over-year decrease of 1013.02%. This contributed to the annual value of $22.2 million for FY2024, which is 523.44% down from last year.
  • Per Rockwell Medical's latest filing, its Non-Current Assets stood at $20.0 million for Q3 2025, which was down 1266.02% from $21.0 million recorded in Q2 2025.
  • Rockwell Medical's Non-Current Assets' 5-year high stood at $24.4 million during Q3 2023, with a 5-year trough of $10.2 million in Q1 2021.
  • Its 5-year average for Non-Current Assets is $16.8 million, with a median of $13.3 million in 2021.
  • As far as peak fluctuations go, Rockwell Medical's Non-Current Assets plummeted by 1475.99% in 2022, and later soared by 12284.36% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Non-Current Assets stood at $13.3 million in 2021, then fell by 14.76% to $11.3 million in 2022, then soared by 106.65% to $23.4 million in 2023, then fell by 5.23% to $22.2 million in 2024, then fell by 9.95% to $20.0 million in 2025.
  • Its last three reported values are $20.0 million in Q3 2025, $21.0 million for Q2 2025, and $20.9 million during Q1 2025.